Extension of Expiration Date for PAR-14-288 "NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (UH2/UH3)"

Notice Number: NOT-NS-17-013

Key Dates
Release Date:  February 6, 2017

Related Announcements
PAR-14-288

Issued by
National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this Notice is to inform interested applicants that the expiration date for the Funding Opportunity Announcement (FOA) PAR-14-288 "NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (UH2/UH3)" will be extended by one receipt cycle. An additional non-AIDS application due date of July 18, 2017, and AIDS and AIDS-related applications due date on September 7, 2017 has been added for this FOA. This FOA expires on September 8, 2017.

The Key Dates table is updated accordingly:

Part 1. Overview Information

Key Dates

Application Due Date(s)

October 21, 2014; February 11, 2015; August 11, 2015; February 11, 2016; August 11, 2016; February 8, 2017; July 18, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

January 7, 2015; May 7, 2015; September 7, 2015; May 7, 2016; September 7, 2016; and May 7, 2017; September 7, 2017, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review

February 2015; June 2015; November 2015; June 2016; November 2016; June 2017; November 2017

Advisory Council Review

May 2015; October 2015; January 2016; October 2016; January 2017; October 2017; January 2018

Earliest Start Date(s)

July 2015

Expiration Date

September 8, 2017

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Chris Boshoff, Ph.D.,
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: chris.boshoff@nih.gov